Compared to HC, we found that IL1β—the source ligand of the IL1β–IL1R2 pair—exhibited increased expression in CD16 + monocytes in AIDP, while IL1R2—the target receptor—exhibited increased expression in CD14 + monocytes. Here, FCGR3A is linked to Guillain-Barre syndrome, familial.